About Sequome
Sequome is a company founded in 2022.. Sequome has raised $10.65 million across 1 funding round. Sequome operates in a competitive market with competitors including Orphalan, PharmaReview, NIMBLE Diagnostics, OneroRx and Nutrasource, among others.
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10.65 M (USD)
in 1 rounds
-
Latest Funding Round
$10.65 M (USD), Series B
Jun 25, 2025
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Sequome
Sequome has successfully raised a total of $10.65M through 1 strategic funding round. The most recent funding activity was a Series B round of $10.65 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $10.6M
-
First Round
First Round
(25 Jun 2025)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2025 | Amount | Series B - Sequome | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Sequome
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sequome
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sequome Comparisons
Competitors of Sequome
Sequome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orphalan, PharmaReview, NIMBLE Diagnostics, OneroRx and Nutrasource, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer and provider of access to innovative treatments to patients with rare diseases
|
|
| domain | founded_year | HQ Location |
Pharmaceutical review services are provided to the life sciences industry.
|
|
| domain | founded_year | HQ Location |
Non-invasive diagnostic devices for cardiovascular stent monitoring are developed.
|
|
| domain | founded_year | HQ Location |
Telepharmacy services are delivered via an online platform for consultations.
|
|
| domain | founded_year | HQ Location |
Marketing services are provided for healthcare, nutraceutical, and pharmaceutical sectors.
|
|
| domain | founded_year | HQ Location |
Invests in biotech companies via global networks and partnerships for disease treatments.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Sequome
When was Sequome founded?
Sequome was founded in 2022 and raised its 1st funding round 3 years after it was founded.
Is Sequome a funded company?
Sequome is a funded company, having raised a total of $10.65M across 1 funding round to date. The company's 1st funding round was a Series B of $10.65M, raised on Jun 25, 2025.
What does Sequome do?
Sequome was founded in 2022 as a provider in the biotechnology sector. Sequences are decoded and designed by the company to advance sequence-based medicines, where sequences refer to ordered outcomes linked to specific causes. An AI system called Gene Genie is being developed for enhanced decoding and design processes. Operations focus on sequence innovation without specified geographic details.
Who are the top competitors of Sequome?
Sequome's top competitors include Droplet, Orphalan and PharmaReview.